Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-jwnkl Total loading time: 0 Render date: 2024-07-11T12:24:21.604Z Has data issue: false hasContentIssue false

Dictionary

Published online by Cambridge University Press:  03 July 2022

Edited by
Runjan Chetty ,
Kumarasen Cooper ,
Carol Cheung  and
Srinivas Mandavilli
Runjan Chetty
Affiliation:
University of Toronto
Kumarasen Cooper
Affiliation:
University of Pennsylvania
Carol Cheung
Affiliation:
University of Toronto
Srinivas Mandavilli
Affiliation:
Hartford Hospital
Get access
Type
Chapter
Information
Leong's Manual of Diagnostic Biomarkers for Immunohistology , pp. 375 - 426
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Selected references

Ansari-Lari, MA, Staebler, A, Zaino, RJ, et al. Distinction of endocervical and endometrial adenocarcinomas: Immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;28:160–7.CrossRefGoogle ScholarPubMed
Armes, JE, Lourie, R, De Silva, M, et al. Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16INK4A protein. Int J Gynecol Pathol 2005;24:363–8.Google Scholar
Bodner-Adler, B, Bodner, K, Czerwenka, K, et al. Expression of p16 protein in patients with uterine smooth muscle tumors: An immunohistochemical analysis. Gynecol Oncol 2005;96:62–6.CrossRefGoogle ScholarPubMed
Dray, M, Russell, P, Dalrymple, C, et al. p16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix: I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005;37:112–24.Google Scholar
Kalof, AN, Evans, MF, Simmons-Arnold, L, Beatty, BG, Cooper, K. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: Potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol 2005;29:674–9.Google Scholar
Klaes, R, Friedrich, T, Spitkovsky, D, et al. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276–84.CrossRefGoogle ScholarPubMed
Qiao, X, Bhuiya, TA, Spitzer, M. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Lower Genital Tract Dis 2005;9:100–7.Google Scholar
Sano, T, Oyama, T, Kashiwabara, K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153:1741–8.CrossRefGoogle ScholarPubMed

Selected references

Lloyd, RV, Jin, L, Qian, X, Kulig, E. Aberrant p27kipl expression in endocrine and other tumors. Am J Pathol 1997;150:401–7.Google Scholar
Toyoshima, H, Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity is related to p21. Cell 1994;78:67–74.CrossRefGoogle ScholarPubMed
Hengst, L, Reed, SI. Translational control of p27kipl accumulation during the cell cycle. Science 1996;271:1861–4.CrossRefGoogle Scholar

Selected references

Alomari, AK, Glusac, EJ, McNiff, JM. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma. J Cutan Pathol 2014;41:839–45.CrossRefGoogle ScholarPubMed
Geddert, H, Kiel, S, Heep, HJ, et al. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol 2003;34:850–6.Google Scholar
Righi, L, Graziano, P, Fornari, A, et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: A retrospective study of 103 cases with surgical correlation. Cancer 2011;117:3416–23.Google Scholar
Tilson, MP, Bishop, JA. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol 2014;8:141–5.Google Scholar
Zhang, HJ, Xue, WC, Siu, MK, et al. P63 expression in gestational trophoblastic disease: Correlation with proliferation and apoptotic dynamics. Int J Gynecol Pathol 2009;28:172–8.Google Scholar

Selected references

Batsakis, JG, El-Naggar, AK. p53: 15 years after discovery. Adv Anat Pathol 1995;2:71–88.Google Scholar
Casey, L, Kobel, M, Ganesan, R, et al. A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy. Histopathology 2017;71(5):736–42.CrossRefGoogle ScholarPubMed
Chang, F, Syrjanen, S, Tervahauta, A, Syrjanen, K. Tumorigenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993;68:653–61.Google Scholar
Kobel, M, Ronnett, BM, Singh, N, Soslow, RA, Gilks, CB, McCluggage, WG. Interpretation of P53 immunohistochemistry in endometrial carcinomas: Toward increased reproducibility. Int J Gynecol Pathol 2019;38 Suppl 1:S123–S131.CrossRefGoogle ScholarPubMed
Singh, N, Leen, SL, Han, G, et al. Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss. Am J Surg Pathol 2015;39(1):52–60.CrossRefGoogle ScholarPubMed
Singh, N, et al. p53 IHC is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol 2020;250:336–345.Google Scholar
Talhouk, A, McConechy, MK, Leung, S, et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer 2017;123(5):802–13.Google Scholar
Visvanathan, K, Vang, R, Shaw, P, et al. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: A reproducibility study. Am J Surg Pathol 2011;35(12):1766–75.CrossRefGoogle ScholarPubMed

Selected references

Di Como, CJ, Urist, MJ, Babayan, I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494–501.Google Scholar
Martin, SE, Temm, CJ, Goheen, MP, et al. Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: An immunohistochemical and immunoelectron microscopic study. Mod Pathol 2011;24:1320–6.CrossRefGoogle ScholarPubMed
Weinstein, MH, Signoretti, S, Loda, M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol 2002;15(12):1302–8.CrossRefGoogle ScholarPubMed

Selected references

Bouchard, S, Russo, P, Radu, AP, Adzick, NS. Expression of neuropeptides in normal and abnormal appendices. J Pediatr Surg 2001;36:1222–6.Google Scholar

Selected references

Aldinger, KA, Hickey, RC, Ibanez, ML, Samaan, NA. Parathyroid carcinoma: A clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer. Cancer 1982;49:388–97.Google Scholar
Brown, EM. PTH secretion in vivo and in vitro: Regulation by calcium and other secretagogues. Mineral Electrolyte Metal 1982;8:130–50.Google ScholarPubMed
Chen, HL, Demiralp, B, Schneider, A, et al. Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 2002;277:19374–81.Google ScholarPubMed

Selected references

Bouvet, M, Nardin, SR, Burton, DW, et al. Parathyroid hormone-related protein as a novel tumor marker in pancreatic adenocarcinoma. Pancreas 2002;24:284–90.Google Scholar
Burtis, WJ, Brady, TG, Orloff, JJ, et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990;322:1106–12.CrossRefGoogle ScholarPubMed

Selected references

Daniel, L, Lechevallier, E, Giorgi, R, et al. Pax-2 expression in adult renal tumors. Hum Pathol 2001; 32:282–7.CrossRefGoogle ScholarPubMed
Dressler, GR, Douglass, EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992;89:1179–83.Google Scholar
Ordonez, NG. Value of Pax2 immunostaining in tumor diagnosis: A review and update. Adv Anat Pathol 2012:19:401–9.Google ScholarPubMed
Ozcan, A, Liles, N, Coffey, D, et al. PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: A comprehensive comparison. Am J Surg Pathol 2011;35:1837–47.Google Scholar
Rabban, JT, Mcalhany, S, Lerwill, MF, et al. Pax2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol 2010;34:137–46.Google Scholar

Selected references

O’Brien, P, Morin, P Jr, Ouellette, RJ, et al. The Pax-5 gene: A pluripotent regulator of B-cell differentiation and cancer disease. Cancer Res 2011;71:7345–50.Google ScholarPubMed
Baker, SJ, Reddy, EP. B cell differentiation: Role of E2A and Pax5/BSAP transcription factors. Oncogene 1995 11:413–26.Google Scholar
Desouki, MM, Post, GR, Cherry, D, et al. PAX-5: A valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res 2010;8:84–8.Google Scholar
Morgenstern, DA, Hasan, F, Gibson, S, et al. PAX5 expression in nonhematopoietic tissues: Reappraisal of previous studies. Am J Clin Pathol 2010;133:407–15.CrossRefGoogle ScholarPubMed

Selected references

Laury, AR, Perets, R, Piao, H, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 2011;35:816–26.CrossRefGoogle ScholarPubMed
Liang, L, Zheng, W, Liu, J, et al. Assessment of the utility of PAX8 immunohistochemical stain in diagnosing endocervical glandular lesions. Arch Pathol Lab Med 2016;140:148–52.CrossRefGoogle ScholarPubMed

Selected references

Park, JY, Hong, SM, Klimstra, DS, et al. Pdx1 expression in pancreatic precursor lesions and neoplasms. Appl Immunohistochem Mol Morphol 2011;19(5):444–9.Google Scholar
Sakai, H, Eishi, Y, Li, X-L, et al. PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 2004;53(3):323–30.CrossRefGoogle ScholarPubMed
Srivastava, A, Hornick, .L. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 2009;33(4):626–32.CrossRefGoogle ScholarPubMed

Selected references

Cordon-Cardo, C, O’Brien, JP, Boccia, J, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277–87.Google Scholar
Lopes, JM, Bruland, OS, Bjekehagen, B, et al. Synovial sarcoma: Immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance. Pathol Res Pract 1997;193:21–36.Google Scholar
Scheffer, GL, Pijnenborg, AC, Smit, EF, et al. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002;55:332–9.Google Scholar

Selected references

Juan, G, Traganos, F, James, WM, et al. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 1998;32:71–7.Google Scholar
Ribalta, T, McCutcheon, IE, Aldape, KD, et al. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 2004;28:1532–6.Google Scholar
Shibata, K, Ajiro, K. Cell cycle-dependent suppressive effect of histone H1 on mitosis-specific H3 phosphorylation. J Biol Chem 1993;268:18431–34.Google Scholar
Tetzlaff, MT, Curry, JL, Ivan, D, et al. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 2013;26:1153–60.Google Scholar
Voss, SM, Riley, MP, Lokhandwala, PM, et al. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Am J Surg Pathol 2015;39:13–24.Google Scholar

Selected references

Earle, KM, Dillard, SH Jr. Pathology of adenomas of the pituitary gland. Excerpta Medica International Congress Series No. 303, 1973, pp. 3–16.Google Scholar
Hardy, J, Vezina, JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol 1976;15:261–5.Google Scholar
Robert, F. Electron microscopy of human pituitary tumors. In: Tindall, GT, Collins, WF. eds. Clinical management of pituitary disorders. New York: Raven Press, 1979, pp. 113–31.Google Scholar

Selected references

Koshida, K, Uchibayashi, T, Yamamoto, H, et al. A potential use of a monoclonal antibody to placental alkaline phosphatase (PLAP) to detect lymph node metastases of seminoma. J Urol 1996;155:337–41.Google Scholar
Losch, A, Kainz, C. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease. Acta Obstet Gynecol Scand 1996;75:753–6.CrossRefGoogle ScholarPubMed
Manivel, JC, Jessurun, J, Wick, MR, et al. Placental alkaline phosphatase immunoreactivity in testicular germ cell neoplasms. Am J Surg Pathol 1987;11:21–9.Google Scholar
Wick, MR, Swanson, PE, Manivel, JC. Placental-like alkaline phosphatase reactivity in human tumors: An immunohistochemical study of 520 cases. Hum Pathol 1987;18:946–54.Google Scholar

Selected references

Amin, MB, Mezger, E, Zarbo, RJ. Detection of Pneumocystis carinii: Comparative study of monoclonal antibody and silver staining. Am J Clin Pathol 1992;98:13–18.CrossRefGoogle ScholarPubMed

Selected references

Plouzek, CA, Leslie, KK, Stephens, JK, et al. Differential gene expression in the amnion, chorion, and trophoblast of the human placenta. Placenta 1993;14:277–85.CrossRefGoogle ScholarPubMed
Sabet, LM, Daya, D, Stead, R, et al. Significance and value of immunohistochemical localization of pregnancy specific proteins in feto-maternal tissue throughout pregnancy. Mod Pathol 1989;2:227–32.Google ScholarPubMed
Waterhouse, R, Ha, C, Dvcksler, GS. Murine CD9 is the receptor for pregnancy-specific glycoprotein 17. J Exp Med 2002;195:277–82.Google Scholar
Wright, C, Angus, B, Napier, J, et al. Prognostic factors in breast cancer: Immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status. J Pathol 1987;153:325–31.Google Scholar

Selected references

Keshgegian, AA. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma: Immunocytochemical hormone receptors and prognostic factors. Arch Pathol Lab Med 1994;118:240–4.Google ScholarPubMed
Leong, AS-Y, Milios, J. Comparison of antibodies to estrogen and progesterone receptors and the influence of microwave antigen retrieval. Appl Immunohistochem 1993;1:282–8.Google Scholar
MacGrogan, G, Soubeyran, I, De Mascarei, I, et al. Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas: A correlative study of 942 cases. Appl Immunohistochem 1996;4:219–27.Google Scholar

Selected references

Carreras, J, Lopez-Guillermo, A, Roncador, G, et al. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 2009; 27(9):1470–6.CrossRefGoogle ScholarPubMed
Cetinozman, F, Koens, L, Jansen, PM, et al. Programmed death-1 expression I cutaneous B cell lymphoma. J Cutan Pathol 2014; 41:14–21.Google Scholar
Dorfman, DM, Brown, JA, Shahsafaei, A, et al. Programmed Death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T cell lymphoma. Am J Surg Pathol 2006; 30(7):802–10.Google Scholar
Muenst, S, Dirnhofer, S, Tzankov, A. Distribution of PD-1+ lymphocytes in reactive lymphadenopathies. Pathobiology 2010;77:24–27.CrossRefGoogle ScholarPubMed
Muenst, S, Hoeller, S, Willi, N, et al. Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis Markers 2010; 29: 47–53.Google Scholar
Nam-Cha, SH, Roncador, G, Sanchez-Verde, L, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 2008;32(8):1252–7.CrossRefGoogle ScholarPubMed

Selected references

Bravo, R, Macdonald-Bravo, H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 1987;105:1549–54.CrossRefGoogle ScholarPubMed
Burford-Mason, AP, MacKay, AJ, Cummins, M, et al. Detection of proliferating cell nuclear antigen in paraffin-embedded specimens is dependent on preembedding tissue handling and fixation. Arch Pathol Lab Med 1994;118:1007–13.Google Scholar

Selected references

Bostwick, DG. Prostate-specific antigen: Current role in diagnostic pathology of prostatic cancer. Am J Clin Pathol 1994;102 (Suppl 1):S31–S37.Google Scholar

Selected references

Epstein, JI. PSA and PAP as immunohistochemical markers in prostatic cancer. Urol Clin North Am 1993;20:757–70.Google Scholar

Selected references

May, FE, Westley, BR. Trefoil proteins: Their role in normal and malignant cells. J Pathol 1997;183:4–7.Google Scholar
Poulsom, R. Trefoil peptides. Baillière’s Clin Gastroenterol 1996;10:113–34.Google Scholar
Wysocki, SJ, Iacopetta, BJ, Ingram, DM. Prognostic significance of pS2 mRNA in breast cancer. Eur J Cancer 1994;30A:1882–4.Google ScholarPubMed

Selected references

Djordjevic, B, Hennessy, BT, Li, J, et al. Clinical assessment of PTEN loss in endometrial carcinoma: Immunohistochemistry outperforms gene sequencing. Mod Pathol 2012;25:699–708.Google Scholar
Foo, WC, Rashid, A, Wang, H, et al. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. Hum Pathol 2013; 44: 1024–30.CrossRefGoogle ScholarPubMed
Govender, D, Chetty, R. Gene of the month: PTEN. J Clin Pathol 2012;65:601–3.Google ScholarPubMed
McMenamin, ME, Soung, P, Perera, S, et al. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 1999;59:4291–6.Google ScholarPubMed
Perren, A, Weng, LP, Boag, AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999; 155: 1253–60.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×